Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
13.8M
-
Number of holders
-
35
-
Total 13F shares, excl. options
-
5.69M
-
Shares change
-
+1.39M
-
Total reported value, excl. options
-
$99.4M
-
Value change
-
+$24.5M
-
Number of buys
-
27
-
Number of sells
-
-6
-
Price
-
$17.47
Significant Holders of CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) as of Q3 2018
38 filings reported holding CSBR - CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share as of Q3 2018.
CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) has 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.69M shares
of 13.8M outstanding shares and own 41.09% of the company stock.
Largest 10 shareholders include Battery Partners IX, LLC (1.95M shares), NEA Management Company, LLC (1.56M shares), RENAISSANCE TECHNOLOGIES LLC (266K shares), Vanguard Group Inc (231K shares), PERKINS CAPITAL MANAGEMENT INC (181K shares), EAM Investors, LLC (180K shares), INGALLS & SNYDER LLC (159K shares), Granite Investment Partners, LLC (140K shares), Schonfeld Strategic Advisors LLC (125K shares), and JPMORGAN CHASE & CO (124K shares).
This table shows the top 35 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.